4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001916048-26-000014
Chief Commercial Officer sold 7,438 shares at $28.12 ($209,136)
- Chief Commercial Officer acquired 7,438 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Warren Eric · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,438 | $13.24 | $98,479 | 45,838 | D |
| 2026-09-21 | Sale : show line 2 in the form 10b5-1 | −7,438 | $28.12 | $209,136 | 38,400 | D |
| Open-market sales · 7,438 sh · avg $28.12 · $209,136 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-21 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −7,438 | 230,563 | D |
Loading xslF345X06/wk-form4_1790117313.xml…